May 13, 2021

Volume XI, Number 133


May 13, 2021

Subscribe to Latest Legal News and Analysis

May 12, 2021

Subscribe to Latest Legal News and Analysis

May 11, 2021

Subscribe to Latest Legal News and Analysis

May 10, 2021

Subscribe to Latest Legal News and Analysis

Reminder: Self-Disallowing Items on Your Medicare Cost Report

In preparing their 2019 cost reports, Medicare providers should remember that failure to comply with HHS’s self-disallowance requirement can have material financial impacts down the road. Several significant Medicare reimbursement regulations are pending review at the U.S. Court of Appeals for the District of Columbia. To recoup additional payments if these regulations are later invalidated, a provider must self-disallow the costs that were affected by the challenged regulations. This GT Alert outlines HHS’s self-disallowance requirement under the most recently amended cost-reporting regulations, and provides practical considerations for identifying and protesting issues.

Brief History of the Self-Disallowance Requirement

The self-disallowance requirement mandates that a provider identify payments related to the validity of any reimbursement regulation in its cost report. HHS’s self-disallowance requirement has gone through several iterations in the past 30 years.

  • For cost-reporting years before Dec. 31, 2008 – no self-disallowance requirement: The U.S. Supreme Court rejected HHS’s first attempt to impose a self-disallowance requirement to challenge the validity of a reimbursement regulation.1

  • For cost-reporting years ending on or after Dec. 31, 2008 but beginning before Jan. 1, 2016 – no self-disallowance requirement: In 2008, HHS promulgated regulations requiring providers to preserve their right to challenge their Medicare reimbursement by either: (1) including a claim for specific items on their cost report; or (2) self-disallowing items as protest costs in their cost report.2 HHS later abandoned the 2008 regulation after providers challenged the requirement.3

  • For cost reporting years beginning on or after Jan. 1, 2016 – new self-disallowance requirement: HHS reintroduced the self-disallowance requirement as a part of cost report, under which claiming or protesting an item on the cost report is a condition of payment (the “2016 Regulation”).4 Providers must include an appropriate claim for a specific item on its cost report – either by affirmatively claiming reimbursement or expressly self-disallowing the cost by filing the item under protest – to be eligible to receive Medicare reimbursement, either by the Medicare Administrative Contractor (MAC) in a Notice of Program Reimbursement (NPR) or by any reviewing body such as the Provider Reimbursement Review Board (PRRB) or a federal court.

Complying With the 2016 Regulation

The 2016 Regulation may have rebranded the self-disallowance requirement as a cost-reporting mandate, but the process for a provider to disallow a cost remains the same. Section 115 of the Provider Reimbursement Manual, Part 2, is now expressly incorporated in the 2016 Regulation. Providers are required to include an estimated payment amount for each self-disallowed item in the “protested amount” lines of the cost report, and attach a worksheet explaining why a self-disallowance is necessary and how the estimated amount for each of the self-disallowed item was determined.

The biggest complaint about the self-disallowance requirement is that it is difficult to identify reimbursement regulations that a provider may want to challenge years after the cost report is submitted and the NPR is finalized. Below are some considerations for identifying issues to self-disallow:

  • If a provider is participating in group appeals challenging the validity of ongoing reimbursement policies, those issues must be self-disallowed annually on the cost report.

  • Each year, the Federation of American Hospitals and the American Hospital Association submit thoughtful and detailed comments on HHS’s annual proposed rulemakings. These comments are helpful in identifying what issues may be challenged in court.

  • Providers regularly receive invitations to join group appeals to challenge reimbursement regulations. Analyze the potential of each of these challenges with your reimbursement counsel and weigh the costs and benefits of being a named plaintiff versus preserving your appeal rights and waiting for others to litigate the issue. If you decide on the latter course, make sure you properly self-disallow the issue.

  • Remember that the 2016 Regulation acknowledged that it may be difficult for hospitals to obtain sufficient information from state agencies for the purpose of claiming DSH Medicaid-eligible patient days. HHS specifically instructed MACs, in this limited circumstance, to accept one amended cost report submitted within a 12-month period after the provider’s cost report due date, solely for the purpose of revising a claim for DSH by using updated Medicaid-eligible patient days, after a hospital receives updated Medicaid eligibility information from the state.

The second step after identifying the issues for self-disallowance is working with the finance team that handles the cost-reporting process. A provider’s legal department can assist the finance team in complying with the 2016 Regulation by doing the following:

  • Ensure that the protest lines under Worksheet E, Part A and Part B, each contain the total sum of the estimated payment amounts for all self-disallowed items under inpatient and outpatient care, respectively.

  • Don’t forget to attach the protest items worksheet with the as-filed cost report. The worksheet should contain calculations supporting the estimated payment amounts for each of the issues under protest.

In conclusion, issues to consider for self-disallowance in the 2019 cost reports include the reduction in off-campus provider-based departments reimbursement, calculation of 340B drugs, cost outlier reimbursements, and the various DSH issues.

1 Bethesda Hospital Association v. Bowen, 485 U.S. 399, 403-04 (1988) (concluding that providers could claim dissatisfaction without incorporating their challenges in the cost reports).

2 42 C.F.R. § 405.1835 (2008).

3 79 Fed. Reg. 50199-201, 50350-51 (technical amendment to eliminate the self-disallowance requirement for appeals based on untimely final contractor determinations); CMS Ruling 1727-R, available at (conceding that a provider has a right to a MAC or a PRRB hearing for an item the provider did not include on its cost report due to a good faith belief that the item was subject to a payment regulation or other policy that gave the MAC no authority or discretion to make payment in the manner the provider sought); see also e.g. Lee Memorial Hospital v. Sebelius, No. 1:13-cv-00643-RMC (D.D.C.); Banner Heart Hospital v. Burwell, 201 F. Supp. 3d 131 (D.D.C. 2016).

4 80 Fed. Reg. 70298, 70555-580 (Nov. 13, 2015).

©2021 Greenberg Traurig, LLP. All rights reserved. National Law Review, Volume IX, Number 346



About this Author

Michi Tsuda Shareholder Health Care & FDA Practice

Michi Tsuda focuses his practice on operational, regulatory, transactional, and litigation matters in the health care sector. Michi’s clients include hospitals, physician groups, accountable care organizations, management services organizations, private-equity funds, sovereign governments, and health-related joint ventures. He regularly represents private equity clients in the acquisition of health care facilities, with a focus on acute care hospitals, freestanding emergency centers, diagnostic laboratories, and senior care communities, and advises physician practice groups on the...

Mimi Hu Brouillette Of Counsel Denver Health Care & FDA Practice
Of Counsel

Mimi Brouillette focuses her practice on health care reimbursement, regulatory, and transactional matters. Mimi advises clients in Medicare and Medicaid reimbursement compliance and represents providers in appeals before the Provider Reimbursement Review Board, the Administrator of the Centers for Medicare and Medicaid Services (CMS), and in federal courts, as well as in negotiations with the U.S. Department of Health and Human Services (HHS). Mimi’s experience also involves health care regulatory and transactional matters, including mergers, acquisitions and financings; state regulatory...

Francis Serbaroli, Greenberg Traurig Law Firm, New York, Healthcare and Litigation Attorney

Francis J. Serbaroli is a shareholder in the Health Care & FDA Practice of Greenberg Traurig's New York office. Frank has three decades of experience in the health care industry. His clients include health insurers and managed care plans; hospitals, nursing homes, clinics, ambulatory surgery centers and home health agencies, clinical laboratories, renal dialysis providers, faculty practice plans, pharmaceutical companies, and medical device and equipment manufacturers. He handles a wide range of corporate, regulatory, compliance, reimbursement, corporate governance,...